orhan tansel korkmaz
orhan tansel korkmaz
Eskisehir Osmangazi University , School of Medicine, Department of Physiology
Verified email at bu.edu
Title
Cited by
Cited by
Year
7, 8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis
OT Korkmaz, N Aytan, I Carreras, JK Choi, NW Kowall, BG Jenkins, ...
Neuroscience letters 566, 286-291, 2014
482014
Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF …
OT Korkmaz, N Tunçel, M Tunçel, EM Öncü, V Şahintürk, M Çelik
Journal of molecular neuroscience 41 (2), 278-287, 2010
422010
A simple and sensitive LC–ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates
D Yeniceli, E Şener, OT Korkmaz, D Doğrukol-Ak, N Tuncel
Talanta 84 (1), 19-26, 2011
372011
Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum
N Tunçel, OT Korkmaz, N Tekin, E Şener, F Akyüz, M İnal
Journal of Molecular Neuroscience 46 (1), 51-57, 2012
362012
Modulation of corpus striatal neurochemistry by astrocytes and vasoactive intestinal peptide (VIP) in parkinsonian rats
İH Yelkenli, E Ulupinar, OT Korkmaz, E Şener, G Kuş, Z Filiz, N Tunçel
Journal of molecular neuroscience 59 (2), 280-289, 2016
182016
Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats
OT Korkmaz, H Ay, E Ulupınar, N Tunçel
Journal of Molecular Neuroscience 48 (3), 565-573, 2012
142012
Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI–LC–MS (ion trap)
E Sener, OT Korkmaz, D Yeniceli, D Dogrukol-Ak, M Tuncel, N Tuncel
Chromatographia 66 (1), 31-36, 2007
132007
Advantages of vasoactive intestinal peptide for the future treatment of Parkinson's disease
OT Korkmaz, N Tunçel
Current pharmaceutical design 24 (39), 4693-4701, 2018
82018
The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats
F Tore, OT Korkmaz, D Dogrukol-Ak, N Tunçel
Journal of molecular neuroscience 41 (2), 288-293, 2010
82010
Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer’s Disease
OT Korkmaz, H Ay, N Aytan, I Carreras, NW Kowall, A Dedeoglu, N Tuncel
Journal of Molecular Neuroscience 68 (3), 389-396, 2019
42019
Determination of Ochratoxin-A in the brain microdialysates and plasma of awake, freely moving rats using ultra high performance liquid chromatography fluorescence detection method
EMÖ Kaya, OT Korkmaz, DY Uğur, E Şener, AN Tunçel, M Tunçel
Journal of Chromatography B 1125, 121700, 2019
22019
Critical Role of Astrocytes on Striatal Neuro-Chemistry in Vip Treated Parkinsonian Rats
N Tuncel, I Yelkenli, E Ulupınar, OT Korkmaz, E Şener, G Kuş
Humana Press Inc, 2013
12013
Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI-LC-MS (ion trap)
E Şener, OT Korkmaz, D Yeniceli, D Doğrukol-Ak, M Tuncel, N Tuncel
Springer Heidelberg, 2007
12007
Vasoactive Intestinal Peptide (VIP) enhances the striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats
N Tuncel, OT Korkmaz, E Ulupinar, H Ay
JOURNAL OF MOLECULAR NEUROSCIENCE 48, S147-S147, 2012
2012
Antioxidant and anti-apoptotic activity of Vasoactive Intestinal Peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum
OT Korkmaz, N Tuncel, N Tekin, E Şener, F Akyüz, M İnal
Humana Press Inc, 2012
2012
THE EFFECTS OF VASOACTIVE INTESTINAL PEPTIDE ON DURAMATER NITRIC OXIDE LEVELS AND VESSEL-CONTRACTION RESPONSES AT SYMPATHECTOMIZED RATS
F Tore, OT Korkmaz, D Dogrukol-Ak, N Tuncel
NEUROPEPTIDES 43 (5), 413-414, 2009
2009
Vasoactive Intestinal Peptide (Vip) Treatment of Parkinsonian Rats Increases in Thalamic Gamma Amino Butyric Acid (Gaba) Levels, and Changes Nerve Growth Factor (Ngf) Release …
N Tuncel, OT Korkmaz, M Tuncel, EM Öncü, V Şahintürk, M Çelik
Churchill Livingstone, 2009
2009
LC-MS/MS METHOD FOR THE DETERMINATION OF LEVETIRACETAM IN RAT BRAIN MICRODIALYSATE
D Dogrukol-Ak, E Sener, OT Korkmaz, S Torun, L Genc, N Tuncel
The system can't perform the operation now. Try again later.
Articles 1–18